Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2022 Aug 29

PMID 36035295

Authors

Jun Zhou

Weihong Zeng

Ying Zeng

Yukun Li

Zheng Xiao

Juan Zou

Lijun Peng

Jiliang Xia

Xi Zeng

Affiliations

Soon will be listed here.

Abstract

NOSH-Aspirin, which is generated from NO, HS, and aspirin, affects a variety of essential pathophysiological processes, including anti-inflammatory, analgesic, antipyretic, antiplatelet, and anticancer properties. Although many people acknowledge the biological significance of NOSH-Aspirin and its therapeutic effects, the mechanism of action of NOSH-Aspirin and its regulation of tissue levels remains obscure. This is in part due to its chemical and physical features, which make processing and analysis difficult. This review focuses on the biological effects of NOSH-Aspirin and provides a comprehensive analysis to elucidate the mechanism underlying its disease-protective benefits.

Citing Articles

Retracted: Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects.

Methods In Medicine C Comput Math Methods Med. 2023; 2023:9861539.

PMID: 37475941 PMC: 10356319. DOI: 10.1155/2023/9861539.

References

Duo Y, Luo G, Li Z, Chen Z, Li X, Jiang Z . Photothermal and Enhanced Photocatalytic Therapies Conduce to Synergistic Anticancer Phototherapy with Biodegradable Titanium Diselenide Nanosheets. Small. 2021; 17(40):e2103239. DOI: 10.1002/smll.202103239. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Chattopadhyay M, Kodela R, Olson K, Kashfi K . NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochem Biophys Res Commun. 2012; 419(3):523-8. DOI: 10.1016/j.bbrc.2012.02.051. View

Alimoradi H, Greish K, Gamble A, Giles G . Controlled Delivery of Nitric Oxide for Cancer Therapy. Pharm Nanotechnol. 2019; 7(4):279-303. PMC: 6967185. DOI: 10.2174/2211738507666190429111306. View

Zoccarato A, Nabeebaccus A, Oexner R, Santos C, Shah A . The nexus between redox state and intermediary metabolism. FEBS J. 2021; 289(18):5440-5462. DOI: 10.1111/febs.16191. View

Fiorucci S, Antonelli E, Burgaud J, Morelli A . Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf. 2001; 24(11):801-11. DOI: 10.2165/00002018-200124110-00002. View

Kashfi K . Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer Agents. Redox Biol. 2017; 5:420. DOI: 10.1016/j.redox.2015.09.030. View

Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K . Cyclooxygenase-2 in cancer: A review. J Cell Physiol. 2018; 234(5):5683-5699. DOI: 10.1002/jcp.27411. View

Drochioiu G, Tudorachi L, Murariu M . NOSH aspirin may have a protective role in Alzheimer's disease. Med Hypotheses. 2015; 84(3):262-7. DOI: 10.1016/j.mehy.2015.01.008. View

10.

Vane J, Bakhle Y, Botting R . Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38:97-120. DOI: 10.1146/annurev.pharmtox.38.1.97. View

11.

Robbins R, Grisham M . Nitric oxide. Int J Biochem Cell Biol. 1997; 29(6):857-60. DOI: 10.1016/s1357-2725(96)00167-7. View

12.

Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R . Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. J Cell Biochem. 2017; 119(3):2951-2963. DOI: 10.1002/jcb.26509. View

13.

Nandi D, Cheema P, Jaiswal N, Nag A . FoxM1: Repurposing an oncogene as a biomarker. Semin Cancer Biol. 2017; 52(Pt 1):74-84. DOI: 10.1016/j.semcancer.2017.08.009. View

14.

Xu H, Lin F, Wang Z, Yang L, Meng J, Ou Z . CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Lett. 2017; 412:69-80. DOI: 10.1016/j.canlet.2017.09.030. View

15.

Haldar R, Ricon-Becker I, Radin A, Gutman M, Cole S, Zmora O . Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial. Cancer. 2020; 126(17):3991-4001. DOI: 10.1002/cncr.32950. View

16.

Olas B . Hydrogen sulfide in signaling pathways. Clin Chim Acta. 2014; 439:212-8. DOI: 10.1016/j.cca.2014.10.037. View

17.

Zhang X, Qu P, Zhao H, Zhao T, Cao N . COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling. Mol Med Rep. 2019; 20(4):3811-3819. PMC: 6755176. DOI: 10.3892/mmr.2019.10598. View

18.

Fonseca M, Cunha F, Kashfi K, Cunha T . NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain. Pharmacol Res Perspect. 2015; 3(3):e00133. PMC: 4492749. DOI: 10.1002/prp2.133. View

19.

Vannini F, Chattopadhyay M, Kodela R, Rao P, Kashfi K . Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling. Redox Biol. 2015; 6:318-325. PMC: 4556775. DOI: 10.1016/j.redox.2015.08.014. View

20.

Vane J, Botting R . The mechanism of action of aspirin. Thromb Res. 2003; 110(5-6):255-8. DOI: 10.1016/s0049-3848(03)00379-7. View